Cargando…

Impact of free cancer predisposition cascade genetic testing on uptake in Singapore

Cascade testing for cancer predisposition offers a highly efficient and cost-effective method for identifying individuals at increased risk for cancer, in whom targeted interventions can often improve survival. The aim of this study was to determine the impact of free cascade testing on uptake and i...

Descripción completa

Detalles Bibliográficos
Autores principales: Courtney, Eliza, Chok, Amanda Kay-Lyn, Ting Ang, Zoe Li, Shaw, Tarryn, Li, Shao-Tzu, Yuen, Jeanette, Ngeow, Joanne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6744424/
https://www.ncbi.nlm.nih.gov/pubmed/31531230
http://dx.doi.org/10.1038/s41525-019-0096-5
_version_ 1783451366486704128
author Courtney, Eliza
Chok, Amanda Kay-Lyn
Ting Ang, Zoe Li
Shaw, Tarryn
Li, Shao-Tzu
Yuen, Jeanette
Ngeow, Joanne
author_facet Courtney, Eliza
Chok, Amanda Kay-Lyn
Ting Ang, Zoe Li
Shaw, Tarryn
Li, Shao-Tzu
Yuen, Jeanette
Ngeow, Joanne
author_sort Courtney, Eliza
collection PubMed
description Cascade testing for cancer predisposition offers a highly efficient and cost-effective method for identifying individuals at increased risk for cancer, in whom targeted interventions can often improve survival. The aim of this study was to determine the impact of free cascade testing on uptake and identify other associated factors. Demographic and clinical data were gathered prospectively for 183 probands found to have a pathogenic variant associated with cancer predisposition and their 826 first-degree relatives (FDRs). The provision of free cascade testing was significantly associated with uptake (21.6% vs 6.1%; χ(2), P < 0.001). Relationship type between FDR and proband and FDR age also demonstrated significant associations, suggesting greater engagement amongst younger generations. Overall, 29.0% (53/183) of families had at least 1 FDR who underwent cascade testing. Of these families, 67.9% (36/53) had an uptake rate of at least 40.0%. Cost is a significant barrier to cascade testing uptake in Singapore. Tailored interventions targeting underrepresented groups and genetic counseling approaches supporting family communication and decision-making are necessary.
format Online
Article
Text
id pubmed-6744424
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-67444242019-09-17 Impact of free cancer predisposition cascade genetic testing on uptake in Singapore Courtney, Eliza Chok, Amanda Kay-Lyn Ting Ang, Zoe Li Shaw, Tarryn Li, Shao-Tzu Yuen, Jeanette Ngeow, Joanne NPJ Genom Med Article Cascade testing for cancer predisposition offers a highly efficient and cost-effective method for identifying individuals at increased risk for cancer, in whom targeted interventions can often improve survival. The aim of this study was to determine the impact of free cascade testing on uptake and identify other associated factors. Demographic and clinical data were gathered prospectively for 183 probands found to have a pathogenic variant associated with cancer predisposition and their 826 first-degree relatives (FDRs). The provision of free cascade testing was significantly associated with uptake (21.6% vs 6.1%; χ(2), P < 0.001). Relationship type between FDR and proband and FDR age also demonstrated significant associations, suggesting greater engagement amongst younger generations. Overall, 29.0% (53/183) of families had at least 1 FDR who underwent cascade testing. Of these families, 67.9% (36/53) had an uptake rate of at least 40.0%. Cost is a significant barrier to cascade testing uptake in Singapore. Tailored interventions targeting underrepresented groups and genetic counseling approaches supporting family communication and decision-making are necessary. Nature Publishing Group UK 2019-09-13 /pmc/articles/PMC6744424/ /pubmed/31531230 http://dx.doi.org/10.1038/s41525-019-0096-5 Text en © The Author(s) 2019 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Courtney, Eliza
Chok, Amanda Kay-Lyn
Ting Ang, Zoe Li
Shaw, Tarryn
Li, Shao-Tzu
Yuen, Jeanette
Ngeow, Joanne
Impact of free cancer predisposition cascade genetic testing on uptake in Singapore
title Impact of free cancer predisposition cascade genetic testing on uptake in Singapore
title_full Impact of free cancer predisposition cascade genetic testing on uptake in Singapore
title_fullStr Impact of free cancer predisposition cascade genetic testing on uptake in Singapore
title_full_unstemmed Impact of free cancer predisposition cascade genetic testing on uptake in Singapore
title_short Impact of free cancer predisposition cascade genetic testing on uptake in Singapore
title_sort impact of free cancer predisposition cascade genetic testing on uptake in singapore
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6744424/
https://www.ncbi.nlm.nih.gov/pubmed/31531230
http://dx.doi.org/10.1038/s41525-019-0096-5
work_keys_str_mv AT courtneyeliza impactoffreecancerpredispositioncascadegenetictestingonuptakeinsingapore
AT chokamandakaylyn impactoffreecancerpredispositioncascadegenetictestingonuptakeinsingapore
AT tingangzoeli impactoffreecancerpredispositioncascadegenetictestingonuptakeinsingapore
AT shawtarryn impactoffreecancerpredispositioncascadegenetictestingonuptakeinsingapore
AT lishaotzu impactoffreecancerpredispositioncascadegenetictestingonuptakeinsingapore
AT yuenjeanette impactoffreecancerpredispositioncascadegenetictestingonuptakeinsingapore
AT ngeowjoanne impactoffreecancerpredispositioncascadegenetictestingonuptakeinsingapore